Pancreatic cancer is considered rare, with an estimated 67,440 new cases diagnosed in the U.S. in 2024. Even so, it is the third-leading cause of cancer-related death in the U.S.
Prostate cancer treatment has changed a lot in recent years. What one expert calls a previously “boring space” has become one of the most exciting areas in cancer care.
Nebraska Medicine’s dermatology program includes dermatologists with specialized training in Mohs and reconstructive surgery. However, just as important as the surgery itself, is the surgery aftercare plan.
Kathy Folk never expected to become a medical pioneer. But 13 years after her cancer diagnosis, Folk made history as Nebraska’s first outpatient CAR T-cell therapy patient.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?
